No buyers for Biogen Idec

BIIB said it did not receive any definitive offers to buy the company and that it will remain independent. In October, BIIB said it was considering being acquired and had received interest from several parties, including financier Carl Icahn (See BioCentury, Oct. 22, 2007). ...